The role of modelling in the policy decision making process for cancer screening: example of prostate specific antigen screening
Although randomised controlled trials are the preferred basis for policy decisions on cancer screening, it remains difficult to assess all downstream effects of screening, particularly when screening options other than those in the specific trial design are being considered. Simulation models of the...
Saved in:
Main Authors: | Abraham M Getaneh (Author), Eveline AM Heijnsdijk (Author), Harry J de Koning (Author) |
---|---|
Format: | Book |
Published: |
Sax Institute,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shared Decision Making in Prostate-Specific Antigen Testing
by: Alison R. Landrey, et al.
Published: (2013) -
Supporting Informed Decision Making for Prostate Specific Antigen (PSA) Testing on the Web: An Online Randomized Controlled Trial
by: Evans, Rhodri, et al.
Published: (2010) -
The Impact of Prostate-Specific Antigen Screening on Prostate Cancer Incidence and Mortality in China: 13-Year Prospective Population-Based Cohort Study
by: Xiaohao Ruan, et al.
Published: (2024) -
Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis
by: Xiaojian Qin, PhD, et al.
Published: (2021) -
Decision aid for prostate cancer screening in Brazil
by: Renata Oliveira Maciel dos Santos, et al.
Published: (2022)